61/292/2026 - Midodrine 2.5 mg Tablets
About This Opportunity
TranslatedThis tender pertains to the procurement of Midodrine 2.5 mg tablets, a medication used primarily for the treatment of orthostatic hypotension. The tender is likely issued by a governmental or healthcare organization seeking to supply this essential medication to healthcare facilities or pharmacies. Key requirements may include compliance with pharmaceutical regulations, quality assurance standards, and delivery timelines. Bidders are expected to demonstrate their capability to provide the medication in the specified dosage form and quantity, ensuring that all products meet the necessary safety and efficacy criteria. The location for the delivery of the medication will be specified in the tender documents, and it is crucial for bidders to adhere to the outlined terms and conditions. The procurement process aims to ensure that healthcare providers have access to this critical medication, thereby improving patient care for those suffering from conditions related to low blood pressure. Interested parties should prepare their proposals in accordance with the guidelines provided in the tender notice, ensuring that all documentation is complete and submitted by the deadline. This tender represents an important opportunity for pharmaceutical suppliers to contribute to public health initiatives.
This is a supplies contract in the health and medical services, information and communication technology and trade and industry sectors, with a focus on Pharmaceuticals and Manufacturing. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 67.
Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Original language: PortugueseThe tender titled "61/292/2026" pertains to the procurement of Midodrina 2.5 mg Comp, a pharmaceutical product essential for various medical applications. This tender is issued within the context of public health procurement in Portugal, aiming to ensure the availability of this medication for healthcare providers across the country.
The contracting authority is responsible for overseeing the acquisition and distribution of pharmaceuticals, thereby supporting healthcare institutions in delivering effective medical treatment. Midodrina is primarily utilized for the management of orthostatic hypotension, and its procurement is critical for patient care in clinical settings.
Typical requirements for this tender may include compliance with regulatory standards set forth by health authorities, proof of product efficacy, and safety data. Suppliers are expected to demonstrate their capability to meet quality assurance protocols and provide relevant documentation regarding the manufacturing processes. Additionally, bidders should prepare to outline their distribution capacities to ensure timely delivery to healthcare facilities.
Interested parties are encouraged to review the comprehensive requirements and guidelines stipulated in the tender documentation. Participation in this tender process is open to qualified pharmaceutical manufacturers and distributors capable of supplying the specified medication in compliance with the applicable regulations in Portugal.
This tender exemplifies the commitment to maintain a robust supply chain for essential medications within the public health sector, ensuring that healthcare providers have access to necessary treatments for their patients.
Data provenance
This notice is sourced from base_gov_pt and was originally published on February 20, 2026. Last refreshed 4 days ago. Original language: Portuguese. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Unidade Local de Saúde do Algarve, E.P.E
Unidade Local de Saúde do Algarve, E.P.E has issued 659 procurement notices on BidsFactory, including 0 currently open and 613 awarded contracts. Activity concentrates in General Supplies & Services, Health & Medical, and Information & Communication Technology. All notices are published for Portugal. Notices are distributed via base_gov_pt. Most recent publication: June 18, 2026.
Frequently asked questions about this tender
How can I submit a bid?
Visit base_gov_pt to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to BLUEMED UNIPESSOAL, LDA. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by Unidade Local de Saúde do Algarve, E.P.E in Portugal. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
What is the estimated budget?
The estimated contract value is Up to €67. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.
Where will the contract be performed?
The contract is for delivery in Portugal. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.